These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8482361)
1. Transcriptional activation of type I collagen genes by ascorbic acid 2-phosphate in human skin fibroblasts and its failure in cells from a patient with alpha 2(I)-chain-defective Ehlers-Danlos syndrome. Kurata S; Senoo H; Hata R Exp Cell Res; 1993 May; 206(1):63-71. PubMed ID: 8482361 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor inhibits transcription of type I collagen genes and production of type I collagen in cultured human skin fibroblasts in the presence and absence of L-ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Kurata S; Hata R J Biol Chem; 1991 May; 266(15):9997-10003. PubMed ID: 2033086 [TBL] [Abstract][Full Text] [Related]
3. Existence of malfunctioning pro alpha2(I) collagen genes in a patient with a pro alpha 2(I)-chain-defective variant of Ehlers-Danlos syndrome. Hata R; Kurata S; Shinkai H Eur J Biochem; 1988 Jun; 174(2):231-7. PubMed ID: 3383844 [TBL] [Abstract][Full Text] [Related]
4. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI. Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078 [TBL] [Abstract][Full Text] [Related]
5. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914 [TBL] [Abstract][Full Text] [Related]
6. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA. Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227 [TBL] [Abstract][Full Text] [Related]
7. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224 [TBL] [Abstract][Full Text] [Related]
8. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissuelike substance by skin fibroblasts. Hata R; Senoo H J Cell Physiol; 1989 Jan; 138(1):8-16. PubMed ID: 2910890 [TBL] [Abstract][Full Text] [Related]
9. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I]. Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422 [TBL] [Abstract][Full Text] [Related]
10. Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. Weil D; D'Alessio M; Ramirez F; Steinmann B; Wirtz MK; Glanville RW; Hollister DW J Biol Chem; 1989 Oct; 264(28):16804-9. PubMed ID: 2777808 [TBL] [Abstract][Full Text] [Related]
11. Collagen synthesis by cultured skin fibroblasts from siblings with hydroxylysine-deficient collagen. Quinn RS; Krane SM Biochim Biophys Acta; 1979 Jul; 585(4):589-98. PubMed ID: 465542 [TBL] [Abstract][Full Text] [Related]
12. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen. Sasaki T; Arai K; Ono M; Yamaguchi T; Furuta S; Nagai Y Arch Dermatol; 1987 Jan; 123(1):76-9. PubMed ID: 3800425 [TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid and transforming growth factor-beta 1 increase collagen biosynthesis via different mechanisms: coordinate regulation of pro alpha 1(I) and Pro alpha 1(III) collagens. Phillips CL; Tajima S; Pinnell SR Arch Biochem Biophys; 1992 Jun; 295(2):397-403. PubMed ID: 1586167 [TBL] [Abstract][Full Text] [Related]
14. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix. Chiodo AA; Sillence DO; Cole WG; Bateman JF Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954 [TBL] [Abstract][Full Text] [Related]
15. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII. Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389 [TBL] [Abstract][Full Text] [Related]
16. [The effect of ascorbic acid on the collagen synthesis in skin fibroblasts of children with funnel chest]. Tsvetkova TA; Gorokhova TA; Del'vig AA Vopr Med Khim; 1990; 36(4):53-5. PubMed ID: 2238533 [TBL] [Abstract][Full Text] [Related]
17. Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. Nuytinck L; Narcisi P; Nicholls A; Renard JP; Pope FM; De Paepe A J Med Genet; 1992 Jun; 29(6):375-80. PubMed ID: 1619632 [TBL] [Abstract][Full Text] [Related]
18. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246 [TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid preferentially enhances type I and III collagen gene transcription in human skin fibroblasts. Tajima S; Pinnell SR J Dermatol Sci; 1996 Mar; 11(3):250-3. PubMed ID: 8785178 [TBL] [Abstract][Full Text] [Related]
20. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]